Molecular approaches to the detection and monitoring of chronic myeloid leukemia: theory and practice.

[1]  H. Heimpel,et al.  Interferon alfa versus chemotherapy for chronic myeloid leukemia: a meta-analysis of seven randomized trials: Chronic Myeloid Leukemia Trialists' Collaborative Group. , 1997, Journal of the National Cancer Institute.

[2]  C Chastang,et al.  Interferon alfa-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia. French Chronic Myeloid Leukemia Study Group. , 1997, The New England journal of medicine.

[3]  J. Reilly,et al.  BCR-ABL transcript with an e19a2 (c3a2) junction in classical chronic myeloid leukemia. , 1997, Blood.

[4]  H. Heimpel,et al.  Molecular response of CML patients treated with interferon‐α monitored by quantitative Southern blot analysis , 1997 .

[5]  G. Meloni,et al.  Neutrophilic-chronic myeloid leukemia: a distinct disease with a specific molecular marker (BCR/ABL with C3/A2 junction) , 1996, Blood.

[6]  J. Melo,et al.  p190 BCR-ABL mRNA is expressed at low levels in p210-positive chronic myeloid and acute lymphoblastic leukemias. , 1996, Blood.

[7]  J. Goldman,et al.  Kinetics of increasing BCR-ABL transcript numbers in chronic myeloid leukemia patients who relapse after bone marrow transplantation. , 1996, Blood.

[8]  R. V. van Etten,et al.  The cytostatic function of c‐Abl is controlled by multiple nuclear localization signals and requires the p53 and Rb tumor suppressor gene products. , 1996, The EMBO journal.

[9]  G. Martinelli,et al.  Consistent amounts of acute leukemia-associated P190BCR/ABL transcripts are expressed by chronic myelogenous leukemia patients at diagnosis. , 1996, Blood.

[10]  J. Melo,et al.  Lack of correlation between ABL‐BCR expression and response to interferon‐α in chronic myeloid leukaemia , 1996 .

[11]  S. Knuutila,et al.  Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia: a metaphase‐FISH study , 1996, British journal of haematology.

[12]  J. Cigudosa,et al.  BCR‐ABL rearrangement and Variant’Philadelphia chromosome in de novo acute myelogenous leukaemia FAB subtype M1 , 1995, British journal of haematology.

[13]  J. Reiffers,et al.  Chronic myelocytic leukemia patients achieving complete cytogenetic conversion under interferon alpha therapy: minimal residual disease follow-up. , 1995, Leukemia.

[14]  F. Ragione,et al.  Involvement of the cyclin‐dependent kinase‐4 inhibitor (CDKN2) gene in the pathogenesis of lymphoid blast crisis of chronic myelogenous leukaemia , 1995, British journal of haematology.

[15]  G. Huez,et al.  Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals. , 1995, Blood.

[16]  R. Bouabdallah,et al.  Minor breakpoint cluster region (m‐BCR) positive chronic myeloid leukaemia with an acute lymphoblastic leukaemia onset: a case report , 1995, British journal of haematology.

[17]  T. Lion,et al.  Increase of bcr-abl chimeric mRNA expression in tumor cells of patients with chronic myeloid leukemia precedes disease progression. , 1995, Blood.

[18]  H. Kantarjian,et al.  The breakpoint cluster region site in patients with Philadelphia chromosome–positive chronic myelogenous leukemia. Clinical, laboratory, and prognostic correlations , 1995, Cancer.

[19]  J. Goldman,et al.  Variable numbers of BCR‐ABL transcripts persist in CML patients who achieve complete cytogenetic remission with interferon‐α , 1995, British journal of haematology.

[20]  A Ferrant,et al.  Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. , 1995, Blood.

[21]  W. El-Deiry,et al.  BCR-ABL-mediated inhibition of apoptosis with delay of G2/M transition after DNA damage: a mechanism of resistance to multiple anticancer agents. , 1995, Blood.

[22]  D. Delia,et al.  Establishment and molecular characterization of a novel leukemic cell line with Philadelphia chromosome expressing p230 BCR/ABL fusion protein. , 1995, Cancer research.

[23]  J. Radich,et al.  Benign marrow progenitors are enriched in the CD34+/HLA-DRlo population but not in the CD34+/CD38lo population in chronic myeloid leukemia: an analysis using interphase fluorescence in situ hybridization. , 1995, Blood.

[24]  S. Richards,et al.  UK Medical Research Council randomised, multicentre trial of interferon-αn1 for chronic myeloid leukaemia: improved survival irrespective of cytogenetic response , 1995, The Lancet.

[25]  D. Catovsky,et al.  Molecular cytogenetics of chronic myeloid leukemia with atypical t(6;9) (p23;q34) translocation. , 1995, Leukemia.

[26]  R. Bouabdallah,et al.  Philadelphia chromosome‐negative chronic myeloid leukaemia: a report of 14 new cases , 1995, British journal of haematology.

[27]  H. Kantarjian,et al.  Quantification of the breakpoint cluster region rearrangement for clinical monitoring in Philadelphia chromosome-positive chronic myeloid leukemia. , 1995, Blood.

[28]  J. Radich,et al.  Polymerase chain reaction detection of the BCR-ABL fusion transcript after allogeneic marrow transplantation for chronic myeloid leukemia: results and implications in 346 patients. , 1995, Blood.

[29]  K. Ishizaki,et al.  Hemizygous expression of the wild‐type p53 allele may confer a selective growth advantage before complete inactivation of the p53 gene in the progression of chronic myelogenous leukaemia , 1995, British journal of haematology.

[30]  J. Goldman,et al.  Characterization of genomic BCR‐ABL breakpoints in chronic myeloid leukaemia by PCR , 1995, British journal of haematology.

[31]  J. Goldman,et al.  Homozygous deletions of the p16 tumor-suppressor gene are associated with lymphoid transformation of chronic myeloid leukemia. , 1995, Blood.

[32]  N. Cross,et al.  Quantitative PCR techniques and applications. , 1995, British journal of haematology.

[33]  D. Campana,et al.  Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance. , 1995, Blood.

[34]  D. Ma,et al.  Interferon response in chronic myeloid leukaemia correlates with ABL/BCR expression: a preliminary study , 1995, British journal of haematology.

[35]  J. Halsey,et al.  Analysis of molecular breakpoint and m‐RNA transcripts in a prospective randomized trial of interferon in chronic myeloid leukaemia: no correlation with clinical features, cytogenetic response, duration of chronic phase, or survival , 1995, British journal of haematology.

[36]  H. Kantarjian,et al.  Prolonged Survival in Chronic Myelogenous Leukemia after Cytogenetic Response to Interferon- Therapy , 1995, Annals of Internal Medicine.

[37]  H. Kantarjian,et al.  Philadelphia chromosome‐negative chronic myelogenous leukemia with rearrangement of the breakpoint cluster region. Long term follow‐up results , 1995, Cancer.

[38]  H. Heimpel,et al.  Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia. The German CML Study Group. , 1994, Blood.

[39]  H. Kumagai,et al.  Molecular elimination of Ph1 clone in a chronic myelogenous leukemia patient with interferon-alpha alone. , 1994, Leukemia.

[40]  Z. Estrov,et al.  Persistence of dormant leukemic progenitors during interferon-induced remission in chronic myelogenous leukemia. Analysis by polymerase chain reaction of individual colonies. , 1994, The Journal of clinical investigation.

[41]  S. Iwata,et al.  Heterogeneity of the breakpoint in the ABL gene in cases with BCR/ABL transcript lacking ABL exon a2. , 1994, Leukemia.

[42]  J. Radich,et al.  Detection of BCR-ABL fusion genes in adult acute lymphoblastic leukemia by the polymerase chain reaction. , 1994, Leukemia.

[43]  J. Goldman,et al.  Detection of residual leukaemia more than 10 years after allogeneic bone marrow transplantation for chronic myelogenous leukaemia. , 1994, Bone marrow transplantation.

[44]  T. Lion.  Clinical implications of qualitative and quantitative polymerase chain reaction analysis in the monitoring of patients with chronic myelogenous leukemia. The European Investigators on Chronic Myeloid Leukemia Group. , 1994, Bone marrow transplantation.

[45]  M. Kirkland.  ANTISENSE THERAPEUTICS IN HAEMATOLOGICAL MALIGNANCIES , 1994, British journal of haematology.

[46]  J. Román,et al.  Lymphoid blast crisis at the onset of chronic myelogenous leukaemia: molecular evidence , 1994, British journal of haematology.

[47]  T. Fioretos,et al.  No evidence for genomic imprinting of the human BCR gene. , 1994, Blood.

[48]  C. Litz,et al.  Paternal origin of the rearranged major breakpoint cluster region in chronic myeloid leukemia. , 1994, Blood.

[49]  C. Litz,et al.  Chronic myelogenous leukemia: molecular diagnostic considerations. , 1994, Human pathology.

[50]  M. Taniwaki,et al.  Prognostic significance of loss of a chromosome 17p and p53 gene mutations in blast crisis of chronic myelogenous leukaemia , 1994, British journal of haematology.

[51]  J. Goldman,et al.  Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: the case for giving donor leukocyte transfusions before the onset of hematologic relapse. , 1994, Blood.

[52]  B. Clarkson,et al.  A 62-kilodalton tyrosine phosphoprotein constitutively present in primary chronic phase chronic myelogenous leukemia enriched lineage negative blast populations. , 1994, Leukemia.

[53]  H. Döhner,et al.  Detection of chimeric BCR-ABL genes on bone marrow samples and blood smears in chronic myeloid and acute lymphoblastic leukemia by in situ hybridization. , 1994, Blood.

[54]  X. H. Wang,et al.  Variable transcription of BCR-ABL by Ph+ cells arising from hematopoietic progenitors in chronic myeloid leukemia. , 1994, Blood.

[55]  H. Cavé,et al.  Prospective monitoring and quantitation of residual blasts in childhood acute lymphoblastic leukemia by polymerase chain reaction study of delta and gamma T-cell receptor genes. , 1994, Blood.

[56]  Sante Tura,et al.  Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia. , 1994, The New England journal of medicine.

[57]  J. Goldman,et al.  A comparison of the sensitivity of blood and bone marrow for the detection of minimal residual disease in chronic myeloid leukaemia , 1994, British journal of haematology.

[58]  D. Green,et al.  BCR-ABL Maintains Resistance of Chronic Myelogenous Leukemia Cells to Apoptotic Cell Death , 1994 .

[59]  X. H. Wang,et al.  Detection and direct sequence identification of BCR-ABL mRNA in Ph+ chronic myeloid leukemia. , 1993, Experimental hematology.

[60]  K. Goi,et al.  A novel 203 kD aberrant BCR‐ABL product in a girl with Philadelphia chromosome positive acute lymphoblastic leultaemia , 1993, British journal of haematology.

[61]  F. Aversa,et al.  Outcome for patients who relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia. Chronic Leukemia Working Party. European Bone Marrow Transplantation Group , 1993 .

[62]  G. Gahrton,et al.  Bone marrow transplantation for chronic myeloid leukemia: long-term results. Chronic Leukemia Working Party of the European Group for Bone Marrow Transplantation. , 1993, Bone marrow transplantation.

[63]  Nanxin Li,et al.  BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein , 1993, Cell.

[64]  A. Chase,et al.  Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation. , 1993, Blood.

[65]  A. Rimm,et al.  1993 progress report from the International Bone Marrow Transplant Registry. Advisory Committee of the International Bone Marrow Transplant Registry. , 1993, Bone marrow transplantation.

[66]  B. Chapuis,et al.  Adoptive immunotherapy for recurrent CML after BMT. , 1993, Bone marrow transplantation.

[67]  Z. Estrov,et al.  Chronic Myelogenous Leukemia : A Concise Update , 2003 .

[68]  C. Bartram.  Detection of minimal residual leukemia by the polymerase chain reaction: potential implications for therapy. , 1993, Clinica chimica acta; international journal of clinical chemistry.

[69]  D. Ma,et al.  Combined interferon alfa-2a and cytosine arabinoside as first-line treatment for chronic myeloid leukemia. , 1993, Acta haematologica.

[70]  K. Akashi,et al.  T lymphoid/myeloid bilineal crisis in chronic myelogenous leukemia. , 1993, Experimental hematology.

[71]  M. Baccarani,et al.  The type of BCR/ABL junction does not predict the survival of patients with Ph1‐positive chronic myeloid leukaemia , 1993, British journal of haematology.

[72]  S. Sowerby,et al.  DNA sequence analysis of the major breakpoint cluster region of the BCR gene rearranged in Philadelphia-positive human leukemias. , 1993, Oncogene.

[73]  J. Melo,et al.  Expression of the ABL-BCR fusion gene in Philadelphia-positive acute lymphoblastic leukemia. , 1993, Blood.

[74]  P. Martiat,et al.  Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: correlations with acute graft‐versus‐host disease and relapse , 1993, British journal of haematology.

[75]  D. Huhn,et al.  Genetic alterations in the p53 gene in the blast crisis of chronic myelogenous leukemia: analysis by polymerase chain reaction based techniques. , 1993, Leukemia.

[76]  R. Brunning,et al.  Duplication of small segments within the major breakpoint cluster region in chronic myelogenous leukemia. , 1993, Blood.

[77]  J. Rowley,et al.  Cytogenetic clonality in myelodysplastic syndromes studied with fluorescence in situ hybridization: lineage, response to growth factor therapy, and clone expansion , 1993 .

[78]  T. Lion,et al.  Early detection of relapse after bone marrow transplantation in patients with chronic myelogenous leukaemia , 1993, The Lancet.

[79]  C. Bloomfield,et al.  Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: a Cancer and Leukemia Group B Study (8762). , 1992, Blood.

[80]  J. Tanzer,et al.  Quantitative determination of the hybrid Bcr‐Abl RNA in patients with chronic myelogenous leukaemia under interferon therapy , 1992, British journal of haematology.

[81]  K. Ishizaki,et al.  Frequent p53 gene mutations in blast crisis of chronic myelogenous leukemia, especially in myeloid crisis harboring loss of a chromosome 17p. , 1992, Cancer research.

[82]  J. Tanzer,et al.  Polymerase chain reaction detection of residual disease in chronic myeloid leukemia patients in complete cytogenetic remission under interferon with or without chemotherapy. , 1992, Leukemia.

[83]  T. Lion,et al.  Parental origin of chromosomes involved in the translocation t(9;22) , 1992, Nature.

[84]  S. Seeber,et al.  No correlation between the type of bcr-abl hybrid messenger RNA and platelet counts in chronic myelogenous leukemia [letter] , 1992 .

[85]  C. Sawyers,et al.  Dominant negative MYC blocks transformation by ABL oncogenes , 1992, Cell.

[86]  C. Higano,et al.  Use of alpha interferon for the treatment of relapse of chronic myelogenous leukemia in chronic phase after allogeneic bone marrow transplantation. , 1992, Blood.

[87]  C. Westbrook,et al.  The role of molecular techniques in the clinical management of leukemia: Lessons from the philadelphia chromosome , 1992, Cancer.

[88]  S H Neoh,et al.  Quantitation of targets for PCR by use of limiting dilution. , 1992, BioTechniques.

[89]  S. Thibodeau,et al.  Molecular remission occurring after donor leukocyte infusions for the treatment of relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation. , 1992, Bone marrow transplantation.

[90]  A. Rimm,et al.  Progress report from the International Bone Marrow Transplant Registry. , 1992, Bone marrow transplantation.

[91]  B. Neel,et al.  Molecular cloning of cDNAs encoding a guanine-nucleotide-releasing factor for Ras p21 , 1992, Nature.

[92]  M. Negrini,et al.  A new chromosomal breakpoint in Ph positive, bcr negative chronic myelogenous leukemia. Report of a case. , 1992, Cancer genetics and cytogenetics.

[93]  Y. Shaul,et al.  c-abl has a sequence-specific enhancer binding activity , 1992, Cell.

[94]  O. Witte,et al.  Initiation of deregulated growth of multipotent progenitor cells by bcr-abl in vitro. , 1992, Science.

[95]  J. Inazawa,et al.  Absence in Ph-negative, M-BCR rearrangement-positive chronic myelogenous leukemia of linkage between 5' ABL and 3' M-BCR sequences in Philadelphia translocation. , 1992, Leukemia.

[96]  P. Elvin,et al.  Amplification and sequencing of genomic breakpoints located within the M-bcr region by Vectorette-mediated polymerase chain reaction. , 1992, Leukemia.

[97]  M. Olson,et al.  Metaphase and interphase cytogenetics with Alu-PCR-amplified yeast artificial chromosome clones containing the BCR gene and the protooncogenes c-raf-1, c-fms, and c-erbB-2. , 1992, Cancer research.

[98]  R. Salgia,et al.  Tyrosine phosphorylation of rasGAP and associated proteins in chronic myelogenous leukemia cell lines. , 1992, Blood.

[99]  Jean Y. J. Wang,et al.  Cell Cycle—Regulated Binding of c-Abl Tyrosine Kinase to DNA , 1992, Science.

[100]  Emil,et al.  Detection of minimal residual disease by polymerase chain reaction in Philadelphia chromosome-positive chronic myelogenous leukemia following interferon therapy. , 1992, Blood.

[101]  T. Lints,et al.  The hematopoietically expressed vav proto-oncogene shares homology with the dbl GDP-GTP exchange factor, the bcr gene and a yeast gene (CDC24) involved in cytoskeletal organization. , 1992, Oncogene.

[102]  A. Barrett,et al.  Donor leukocyte infusions for chronic myeloid leukemia in relapse after allogeneic bone marrow transplantation [letter] , 1992 .

[103]  N. Kamada,et al.  Molecular elimination of the minimal residual Ph1 clone with IFNα in CML , 1992, The Lancet.

[104]  G. Daley,et al.  Blast crisis in a murine model of chronic myelogenous leukemia. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[105]  M. Bar‐eli,et al.  Abnormalities of the retinoblastoma gene in the pathogenesis of acute leukemia , 1991 .

[106]  P. Ely,et al.  bcr/abl mRNA DETECTION FOLLOWING BONE MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA , 1991, Transplantation.

[107]  N. Kamada,et al.  Molecular studies of chronic myelogenous leukemia using the polymerase chain reaction , 1991, Cancer.

[108]  A. Gratwohl,et al.  Second transplants for leukaemic relapse after bone marrow transplantation: high early mortality but favourable effect of chronic GVHD on continued remission. A REPORT BY THE EBMT LEUKAEMIA WORKING PARTY , 1991, British journal of haematology.

[109]  J. Ritz,et al.  Clinical significance of bcr-abl gene rearrangement detected by polymerase chain reaction after allogeneic bone marrow transplantation in chronic myelogenous leukemia. , 1991, Blood.

[110]  E. Estey,et al.  Significance of the P210 versus P190 molecular abnormalities in adults with Philadelphia chromosome-positive acute leukemia. , 1991, Blood.

[111]  O. Witte,et al.  The BCR gene encodes a novel serine/threonine kinase activity within a single exon , 1991, Cell.

[112]  H. Saito,et al.  Absence of the human retinoblastoma gene product in the megakaryoblastic crisis of chronic myelogenous leukemia. , 1991, Blood.

[113]  K. Mills,et al.  Mapping of breakpoints, and relationship to BCR-ABL RNA expression, in Philadelphia-chromosome-positive chronic myeloid leukaemia patients with a breakpoint around exon 14 (b3) of the BCR gene. , 1991, Leukemia.

[114]  A. Rimm,et al.  T-cell depletion of HLA-identical transplants in leukemia. , 1991, Blood.

[115]  R. Espinosa,et al.  axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase , 1991, Molecular and cellular biology.

[116]  N. Rosenberg,et al.  Differences in oncogenic potency but not target cell specificity distinguish the two forms of the BCR/ABL oncogene. , 1991, Molecular and cellular biology.

[117]  K. Mills,et al.  Does the breakpoint within the major breakpoint cluster region (M-bcr) influence the duration of the chronic phase in chronic myeloid leukemia? An analytical comparison of current literature. , 1991, Blood.

[118]  N. Heisterkamp,et al.  Entire ABL gene is joined with 5'-BCR in some patients with Philadelphia-positive leukemia. , 1991, Blood.

[119]  B. Calabretta,et al.  Selective inhibition of leukemia cell proliferation by BCR-ABL antisense oligodeoxynucleotides. , 1991, Science.

[120]  P. Koduru,et al.  Extramedullary blast crisis in chronic myelogenous leukemia. Demonstration of t‐cell lineage and philadelphia chromosome in a paraspinal tumor , 1991, Cancer.

[121]  E. Bryant,et al.  Chimeric BCR-abl messenger RNA as a marker for minimal residual disease in patients transplanted for Philadelphia chromosome-positive acute lymphoblastic leukemia. , 1991, Blood.

[122]  O. Witte,et al.  BCR sequences essential for transformation by the BCR-ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-dependent manner , 1991, Cell.

[123]  P. Martiat,et al.  Philadelphia-negative (Ph-) chronic myeloid leukemia (CML): comparison with Ph+ CML and chronic myelomonocytic leukemia. The Groupe Français de Cytogénétique Hématologique. , 1991, Blood.

[124]  A. Hagemeijer,et al.  bcr-abl mRNA lacking abl exon a2 detected by polymerase chain reaction in a chronic myelogeneous leukemia patient. , 1991, Leukemia.

[125]  J. Wang,et al.  Detection of BCR-ABL proteins in blood cells of benign phase chronic myelogenous leukemia patients. , 1991, Cancer research.

[126]  M. Bar‐eli,et al.  The spectrum of molecular alterations in the evolution of chronic myelocytic leukemia. , 1991, The Journal of clinical investigation.

[127]  P. Koduru,et al.  Correlation between molecular and clinical events in the evolution of chronic myelocytic leukemia to blast crisis , 1991 .

[128]  C. Hall,et al.  Bcr encodes a GTPase-activating protein for p21rac , 1991, Nature.

[129]  E. Thiel,et al.  Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reaction , 1991, The Lancet.

[130]  M. Slovak,et al.  Persistence of bcr-able gene expression following bone marrow transplantation for chronic myelogenous leukemia in chronic phase. , 1991, Transplantation.

[131]  O. Witte,et al.  BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias , 1991, Molecular and cellular biology.

[132]  R. Kurzrock,et al.  Interferon-alpha produces sustained cytogenetic responses in chronic myelogenous leukemia. Philadelphia chromosome-positive patients. , 1991, Annals of internal medicine.

[133]  J. Compton,et al.  Nucleic acid sequence-based amplification , 1991, Nature.

[134]  A. Morley,et al.  Molecular diagnosis of Philadelphia negative CML using the polymerase chain reaction and DNA analysis: clinical features and course of M-bcr negative and M-bcr positive CML. , 1991, Leukemia.

[135]  J. Wang,et al.  Activation of tyrosinase kinase and microfilament-binding functions of c-abl by bcr sequences in bcr/abl fusion proteins , 1991, Molecular and cellular biology.

[136]  J. Craig,et al.  Philadelphia positive acute lymphoblastic leukemia in adults: age distribution, BCR breakpoint and prognostic significance. , 1991, Leukemia.

[137]  J. Shuster,et al.  Philadelphia chromosome and monosomy 7 in childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study. , 1991, Blood.

[138]  G. Morgan,et al.  Detection of residual leukemia after bone marrow transplant for chronic myeloid leukemia: role of polymerase chain reaction in predicting relapse. , 1991, Blood.

[139]  J. Fletcher,et al.  Translocation (9;22) is associated with extremely poor prognosis in intensively treated children with acute lymphoblastic leukemia. , 1991, Blood.

[140]  K. Suryanarayan,et al.  Consistent involvement of the bcr gene by 9;22 breakpoints in pediatric acute leukemias. , 1991, Blood.

[141]  W. Wilmanns,et al.  Donor Leukocyte Transfusions for Treatment of Recurrent Chronic Myelogenous Leukemia in Marrow Transplant Patients , 1990 .

[142]  D. Schaid,et al.  The location of the Philadelphia chromosomal breakpoint site and prognosis in chronic granulocytic leukemia. , 1990, Leukemia.

[143]  C. Mecucci,et al.  P190 BCR/ABL transcript in a case of Philadelphia-positive multiple myeloma. , 1990, Leukemia.

[144]  G. Saglio,et al.  New type of Bcr/Abl junction in Philadelphia chromosome-positive chronic myelogenous leukemia. , 1990, Blood.

[145]  N. Heisterkamp,et al.  Ph-negative chronic myeloid leukemia: molecular analysis of ABL insertion into M-BCR on chromosome 22. , 1990, Blood.

[146]  D Pinkel,et al.  Detection of bcr-abl fusion in chronic myelogeneous leukemia by in situ hybridization , 1990, Science.

[147]  G. Saglio,et al.  Alternative BCR/ABL transcripts in chronic myeloid leukemia [letter; comment] , 1990 .

[148]  G. Saglio,et al.  Alternative BCR/ABL transcripts in chronic myeloid leukemia. , 1990, Blood.

[149]  M. Gulley,et al.  Bcr/abl recombinant DNA analysis versus karyotype in the diagnosis and therapeutic monitoring of chronic myeloid leukemia. , 1990, American journal of clinical pathology.

[150]  Seamus J. Martin,et al.  Induction of apoptosis (programmed cell death) in human leukemic HL-60 cells by inhibition of RNA or protein synthesis. , 1990, Journal of immunology.

[151]  P. Martiat,et al.  Use of pulsed field gel electrophoresis to characterize BCR gene involvement in CML patients lacking M-BCR rearrangement. , 1990, Leukemia.

[152]  R. Foà,et al.  ABL proteins in Philadelphia‐positive acute leukaemias and chronic myelogenous leukaemia blast crises , 1990, British journal of haematology.

[153]  P. Martiat,et al.  The role of alternative splicing patterns of BCR/ABL transcripts in the generation of the blast crisis of chronic myeloid leukaemia , 1990, British journal of haematology.

[154]  Y. C. Chen,et al.  Chromosome and bcr rearrangement in chronic myelogenous leukaemia and their correlation with clinical states and prognosis of the disease , 1990, British journal of haematology.

[155]  F. Behm,et al.  Philadelphia chromosome positive childhood acute lymphoblastic leukemia: clinical and cytogenetic characteristics and treatment outcome. A Pediatric Oncology Group study , 1990 .

[156]  J. Sklar,et al.  Expression of bcr-abl fusion transcripts following bone marrow transplantation for Philadelphia chromosome-positive leukemia. , 1990, Leukemia.

[157]  P. Martiat,et al.  Detection of residual BCR/ABL transcripts in chronic myeloid leukaemia patients in complete remission using the polymerase chain reaction and nested primers , 1990, British journal of haematology.

[158]  J. Reiffers,et al.  Long-term follow-up after bone marrow transplantation for chronic myelogenous leukemia: factors associated with relapse. , 1990, Bone marrow transplantation.

[159]  A. Hagemeijer,et al.  A novel variant of the bcr-abl fusion product in Philadelphia chromosome-positive acute lymphoblastic leukemia. , 1990, Leukemia.

[160]  A. Keating,et al.  Neutrophilic myelofibrosis presenting as philadelphia chromosome negative BCR non‐rearranged chronic myeloid leukemia , 1990, American journal of hematology.

[161]  P. Martiat,et al.  False-positive results with PCR to detect leukaemia-specific transcript , 1990, The Lancet.

[162]  P. Martiat,et al.  Interstitial insertion of varying amounts of ABL-containing genetic material into chromosome 22 in Ph-negative CML. , 1990, Leukemia.

[163]  A. Elefanty,et al.  bcr‐abl, the hallmark of chronic myeloid leukaemia in man, induces multiple haemopoietic neoplasms in mice. , 1990, The EMBO journal.

[164]  J. Rowley,et al.  Recurring chromosome abnormalities in leukemia and lymphoma. , 1990, Seminars in hematology.

[165]  G. Jenster,et al.  Acute leukaemia in bcr/abl transgenic mice , 1990, Nature.

[166]  O. Witte,et al.  Tyrosine kinase activity and transformation potency of bcr-abl oncogene products. , 1990, Science.

[167]  G. Grosveld,et al.  Chronic myeloid leukemia may be associated with several bcr-abl transcripts including the acute lymphoid leukemia-type 7 kb transcript. , 1990, Blood.

[168]  J. Gabert,et al.  Residual bcr/abl transcripts in chronic myeloid leukaemia , 1990, The Lancet.

[169]  G. Daley,et al.  Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome. , 1990, Science.

[170]  M. Vidaud,et al.  Frequent detection of minimal residual disease by use of the polymerase chain reaction in long-term survivors after bone marrow transplantation for chronic myeloid leukemia. , 1990, Leukemia.

[171]  R. Berger,et al.  Philadelphia-positive acute leukemia. Cytogenetic and molecular aspects. , 1990, Cancer genetics and cytogenetics.

[172]  R. Kurzrock,et al.  Philadelphia chromosome-negative chronic myelogenous leukemia without breakpoint cluster region rearrangement: a chronic myeloid leukemia with a distinct clinical course. , 1990, Blood.

[173]  C. Sawyers,et al.  Significance of residual leukaemia transcripts after bone marrow transplant for CML , 1990, The Lancet.

[174]  L. Wiedemann,et al.  Characterization of the translocation breakpoint sequences in philadelphia‐positive acute lymphoblastic leukemia , 1990, Genes, chromosomes & cancer.

[175]  P. Martiat,et al.  The position of the M‐BCR breakpoint does not predict the duration of chronic phase or survival in chronic myeloid leukaemia , 1990, British journal of haematology.

[176]  K. Mills,et al.  Further evidence that the site of the breakpoint in the major breakpoint cluster region (M-bcr) may be a prognostic indicator. , 1989, Leukemia.

[177]  V. Rotter,et al.  Rearrangements in the p53 gene in Philadelphia chromosome positive chronic myelogenous leukemia. , 1989, Blood.

[178]  J. Gabert,et al.  DETECTION OF RESIDUAL bcr/abl TRANSLOCATION BY POLYMERASE CHAIN REACTION IN CHRONIC MYELOID LEUKAEMIA PATIENTS AFTER BONE-MARROW TRANSPLANTATION , 1989, The Lancet.

[179]  C. Marcelle,et al.  Analysis of BCR‐ABL mRNA in chronic myelogenous leukemia patients and identification of a new BCR‐related sequence in human DNA , 1989, Genes, chromosomes & cancer.

[180]  P. Gascón,et al.  Fine mapping of chromosome 22 breakpoints within the breakpoint cluster region (bcr) implies a role for bcr exon 3 in determining disease duration in chronic myeloid leukemia. , 1989, American journal of human genetics.

[181]  D. Baltimore,et al.  The mouse type IV c-abl gene product is a nuclear protein, and activation of transforming ability is associated with cytoplasmic localization , 1989, Cell.

[182]  C. Westbrook,et al.  Detection of the Philadelphia chromosome in acute lymphoblastic leukemia by pulsed-field gel electrophoresis. , 1989, Blood.

[183]  D. Ginsburg,et al.  Detection of Philadelphia chromosome-positive cells by the polymerase chain reaction following bone marrow transplant for chronic myelogenous leukemia , 1989 .

[184]  T. Soma,et al.  No correlation between locations of bcr breakpoints and clinical states in Ph1-positive CML patients. , 1989, Leukemia.

[185]  J. Rowley,et al.  Unexpected heterogeneity of BCR-ABL fusion mRNA detected by polymerase chain reaction in Philadelphia chromosome-positive acute lymphoblastic leukemia. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[186]  H. Kantarjian,et al.  Detection of two alternative bcr/abl mRNA junctions and minimal residual disease in Philadelphia chromosome positive chronic myelogenous leukemia by polymerase chain reaction. , 1989, Blood.

[187]  S. Kwok,et al.  Avoiding false positives with PCR , 1989, Nature.

[188]  J. Bosco,et al.  Clinical stage of chronic granulocytic leukaemia and BCR breakpoint location in South‐East Asian patients , 1989, British journal of haematology.

[189]  O. Witte,et al.  Alternative forms of the BCR-ABL oncogene have quantitatively different potencies for stimulation of immature lymphoid cells , 1989, Molecular and cellular biology.

[190]  W. Lange,et al.  Detection by enzymatic amplification of bcr-abl mRNA in peripheral blood and bone marrow cells of patients with chronic myelogenous leukemia. , 1989, Blood.

[191]  G. Morgan,et al.  POLYMERASE CHAIN REACTION FOR DETECTION OF RESIDUAL LEUKAEMIA , 1989, The Lancet.

[192]  S. Raimondi,et al.  Comparative biochemical and cytogenetic studies of childhood acute lymphoblastic leukemia with the Philadelphia chromosome and other 22q 11 variants , 1989 .

[193]  S. Thibodeau,et al.  The bcr Gene in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia , 1989 .

[194]  S. Collins,et al.  Rare occurrence of N-ras point mutations in Philadelphia chromosome positive chronic myeloid leukemia. , 1989, Blood.

[195]  H. Kantarjian,et al.  Ras oncogene mutations are rare late stage events in chronic myelogenous leukemia. , 1989, Blood.

[196]  E. Thomas,et al.  Indications for marrow transplantation in chronic myelogenous leukemia. , 1989, Blood.

[197]  A. Hagemeijer,et al.  Cytogenetic and molecular analysis in Philadelphia negative CML. , 1989, Blood.

[198]  D. Baltimore,et al.  N‐terminal mutations activate the leukemogenic potential of the myristoylated form of c‐abl. , 1989, The EMBO journal.

[199]  R. Berger,et al.  Ph1+bcr- acute leukemias: implication of Alu sequences in a chromosomal translocation occurring in the new cluster region within the BCR gene. , 1989, Oncogene.

[200]  N. Heisterkamp,et al.  Nucleotide sequence of both reciprocal translocation junction regions in a patient with Ph positive acute lymphoblastic leukaemia, with a breakpoint within the first intron of the BCR gene. , 1989, Nucleic acids research.

[201]  J. Wang,et al.  Deletion of an N‐terminal regulatory domain of the c‐abl tyrosine kinase activates its oncogenic potential. , 1989, The EMBO journal.

[202]  K. Sullivan,et al.  HLA-identical marrow transplantation during accelerated-phase chronic myelogenous leukemia: analysis of survival and remission duration. , 1988, Blood.

[203]  J. Goldman,et al.  Rearrangement of the Breakpoint Cluster Region and Expression of P210 BCR-ABL in a "Masked" Philadelphia Chromosome-Positive Acute Myeloid Leukemia , 1988 .

[204]  D. Przepiorka.  Breakpoint zone of bcr in chronic myelogenous leukemia does not correlate with disease phase or prognosis. , 1988, Cancer genetics and cytogenetics.

[205]  T. Pawson,et al.  Non-catalytic domains of cytoplasmic protein-tyrosine kinases: regulatory elements in signal transduction. , 1988, Oncogene.

[206]  R. Kurzrock,et al.  Significance and correlations of molecular analysis results in patients with Philadelphia chromosome-negative chronic myelogenous leukemia and chronic myelomonocytic leukemia. , 1988, The American journal of medicine.

[207]  J U Gutterman,et al.  The molecular genetics of Philadelphia chromosome-positive leukemias. , 1988, The New England journal of medicine.

[208]  G. Saglio,et al.  Variability of the molecular defects corresponding to the presence of a Philadelphia chromosome in human hematologic malignancies. , 1988, Blood.

[209]  R. Chaganti,et al.  Clinical evaluation of a DNA probe assay for the Philadelphia (Ph1) translocation in chronic myelogenous leukemia. , 1988, Leukemia.

[210]  R. Kurzrock,et al.  Philadelphia-negative chronic myelogenous leukemia with breakpoint cluster region rearrangement: molecular analysis, clinical characteristics, and response to therapy. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[211]  R. Silver,et al.  The location of breakpoints within the breakpoint cluster region (bcr) of chromosome 22 in chronic myeloid leukemia. , 1988, Leukemia.

[212]  O. Witte,et al.  Selective transformation of primitive lymphoid cells by the BCR/ABL oncogene expressed in long-term lymphoid or myeloid cultures , 1988, Molecular and cellular biology.

[213]  K. Mills,et al.  The site of the breakpoint within the bcr is a prognostic factor in Philadelphia-positive CML patients. , 1988, Blood.

[214]  K. Ohyashiki,et al.  Analysis of DNA from cells fixed in Carnoy's solution for cytogenetic study. , 1988, Cancer genetics and cytogenetics.

[215]  H. Kantarjian,et al.  Detection of minimal residual bcr/abl transcripts by a modified polymerase chain reaction. , 1988, Blood.

[216]  R. Kurzrock,et al.  Analysis of breakpoints within the bcr gene and their correlation with the clinical course of Philadelphia-positive chronic myelogenous leukemia. , 1988, Blood.

[217]  E. Coustan-Smith,et al.  Variable Philadelphia breakpoints and potential lineage restriction of bcr rearrangement in acute lymphoblastic leukemia , 1988 .

[218]  R. Hoffmann,et al.  Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion. , 1988 .

[219]  W. Gregory,et al.  Bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: importance of a graft‐versus‐leukaemia effect , 1988, British journal of haematology.

[220]  J. Goldman,et al.  Cytogenetic events after bone marrow transplantation for chronic myeloid leukemia in chronic phase. , 1988, Blood.

[221]  S. Smith,et al.  Heterogeneity of genomic fusion of BCR and ABL in Philadelphia chromosome-positive acute lymphoblastic leukemia. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[222]  R. Kriz,et al.  Sequence similarity of phospholipase C with the non-catalytic region of src , 1988, Nature.

[223]  R. Gale,et al.  Molecular abnormalities of bcr and c-abl in chronic myelogenous leukemia associated with a long chronic phase. , 1988, Blood.

[224]  G. Dewald,et al.  Possible cytogenetic distinction between lymphoid and myeloid blast crisis in chronic granulocytic leukemia , 1988, American journal of hematology.

[225]  B. Hjelle,et al.  Transforming genes in chronic myelogenous leukemia. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[226]  M. L. Le Beau,et al.  Long-range mapping of the Philadelphia chromosome by pulsed-field gel electrophoresis. , 1988, Blood.

[227]  D. Bevan,et al.  The correlation of breakpoint cluster region rearrangement and p210 phl/abl expression with morphological analysis of Ph-negative chronic myeloid leukemia and other myeloproliferative diseases. , 1988, Blood.

[228]  Goldie Jh,et al.  Impact of dose-intense chemotherapy on the development of permanent drug resistance. , 1987 .

[229]  N. Heisterkamp,et al.  The BCR/ABL hybrid gene. , 1987, Bailliere's clinical haematology.

[230]  J. Wainscoat,et al.  Molecular diagnosis of haematological disorders using DNA from stored bone marrow slides , 1987, British journal of haematology.

[231]  R. Kurzrock,et al.  Expression of c-abl in Philadelphia-positive acute myelogenous leukemia. , 1987, Blood.

[232]  G. Torelli,et al.  Philadelphia-positive chronic myeloid leukemia with a chromosome 22 breakpoint outside the breakpoint cluster region. , 1987, Blood.

[233]  F. Behm,et al.  Clinical and biologic hallmarks of the Philadelphia chromosome in childhood acute lymphoblastic leukemia. , 1987, Blood.

[234]  A. Hagenbeek,et al.  Nonhomogeneous distribution of leukemia in the bone marrow during minimal residual disease. , 1987, Blood.

[235]  R. Kurzrock,et al.  Molecular analysis of chromosome 22 breakpoints in adult Philadelphia‐positive acute lymphoblastic leukaemia , 1987, British journal of haematology.

[236]  O. Witte,et al.  In vitro transformation of immature hematopoietic cells by the P210 BCR/ABL oncogene product of the Philadelphia chromosome. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[237]  J. Mears,et al.  CML patients in blast crisis have breakpoints localized to a specific region of the BCR , 1987 .

[238]  R. Kurzrock,et al.  Molecular characteristics of chronic myelogenous leukemia in blast crisis. , 1987, Cancer genetics and cytogenetics.

[239]  R. Gale,et al.  DO ONCOGENES DETERMINE CLINICAL FEATURES IN CHRONIC MYELOID LEUKAEMIA? , 1987, The Lancet.

[240]  M. Groudine,et al.  Chronic myelogenous leukemia: amplification of a rearranged c-abl oncogene in both chronic phase and blast crisis. , 1987, Blood.

[241]  H. Kantarjian,et al.  Molecular analysis of interferon-induced suppression of Philadelphia chromosome in patients with chronic myeloid leukemia. , 1987, Blood.

[242]  A. Berrebi,et al.  bcr-abl RNA in patients with chronic myelogenous leukemia. , 1987, Blood.

[243]  M. Greaves,et al.  A novel abl protein expressed in Philadelphia chromosome positive acute lymphoblastic leukaemia positive acute lymphoblastic leukaemia , 1987, Nature.

[244]  J. Bishop.  The molecular genetics of cancer. , 1987, Science.

[245]  I. Hariharan,et al.  cDNA sequence for human bcr, the gene that translocates to the abl oncogene in chronic myeloid leukaemia. , 1987, The EMBO journal.

[246]  R. Kurzrock,et al.  Rearrangement in the breakpoint cluster region and the clinical course in Philadelphia-negative chronic myelogenous leukemia. , 1986, Annals of internal medicine.

[247]  J. Mears,et al.  Frequent and extensive deletion during the 9,22 translocation in CML. , 1986, Blood.

[248]  Bruce A. Roe,et al.  Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene , 1986, Cell.

[249]  T. Ganesan,et al.  Rearrangement of the bcr gene in Philadelphia-chromosome-negative chronic myeloid leukemia. , 1986, Haematology and blood transfusion.

[250]  N. Heisterkamp,et al.  Molecular analysis of both translocation products of a Philadelphia-positive CML patient. , 1986, Nucleic acids research.

[251]  J. Gutterman,et al.  Chronic myelogenous leukaemia: haematological remissions with alpha interferon , 1986, British journal of haematology.

[252]  J W Gray,et al.  Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[253]  L. Kearney,et al.  Correlation between chromosomal abnormalities and blast phenotype in the blast crisis of Ph-positive CGL. , 1986, Cancer genetics and cytogenetics.

[254]  M. Olson,et al.  Electrophoretic separations of large DNA molecules by periodic inversion of the electric field. , 1986, Science.

[255]  A. Reeve,et al.  Genomic diversity correlates with clinical variation in Ph′-negative chronic myeloid leukaemia , 1986, Nature.

[256]  D. Patterson,et al.  Fractionation of large mammalian DNA restriction fragments using vertical pulsed-field gradient gel electrophoresis , 1986, Somatic cell and molecular genetics.

[257]  G. Daley,et al.  Alternative 5′ exons in c-abl mRNA , 1986, Cell.

[258]  H. Deeg,et al.  Marrow transplantation for the treatment of chronic myelogenous leukemia. , 1986, Annals of internal medicine.

[259]  R. Marcus,et al.  Bone marrow transplantation for patients with chronic myeloid leukemia. , 1986, The New England journal of medicine.

[260]  C. Bartram.  Brief Definitive Report , 2022 .

[261]  O. Witte,et al.  Activation of the abl oncogene in murine and human leukemias. , 1985, Biochimica et biophysica acta.

[262]  F. Mitelman,et al.  Variant Ph translocations in chronic myeloid leukemia. , 1985, Cancer genetics and cytogenetics.

[263]  A. Hagemeijer,et al.  Translocation of c-abl to "masked" Ph in chronic myeloid leukemia. , 1985, Cancer genetics and cytogenetics.

[264]  E. Canaani,et al.  Fused transcript of abl and bcr genes in chronic myelogenous leukaemia , 1985, Nature.

[265]  Kees Stam,et al.  Structural organization of the bcr gene and its role in the Ph′ translocation , 1985, Nature.

[266]  D. Golde,et al.  Chronic myelogenous leukemia: recent advances. , 1985, Blood.

[267]  D. Baltimore,et al.  The minimum transforming region of v-abl is the segment encoding protein-tyrosine kinase , 1985, Journal of virology.

[268]  R. Kurzrock,et al.  The human cellular abl gene product in the chronic myelogenous leukemia cell line K562 has an associated tyrosine protein kinase activity. , 1985, Virology.

[269]  R. Davis,et al.  Activation of the c-abl oncogene by viral transduction or chromosomal translocation generates altered c-abl proteins with similar in vitro kinase properties , 1985, Molecular and cellular biology.

[270]  J. Goldman,et al.  GENOMIC ALTERATIONS INVOLVING THE C-MYC PROTO-ONCOGENE LOCUS DURING THE EVOLUTION OF A CASE OF CHRONIC GRANULOCYTIC LEUKAEMIA , 1984, The Lancet.

[271]  D. Schwartz,et al.  Separation of yeast chromosome-sized DNAs by pulsed field gradient gel electrophoresis , 1984, Cell.

[272]  Francisco Cervantes,et al.  Prognostic discrimination in "good-risk" chronic granulocytic leukemia , 1984 .

[273]  M. L. Beau,et al.  Deletion of 5q , 1984 .

[274]  D. Arthur.  Abnormalities of Chromosome 16 , 1984 .

[275]  J. Stephenson,et al.  Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22 , 1984, Cell.

[276]  C. Bloomfield,et al.  Chromosomal abnormalities and their clinical significance in acute lymphoblastic leukemia. Third International Workshop on Chromosomes in Leukemia. , 1983, Cancer research.

[277]  J. Stephenson,et al.  A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia , 1982, Nature.

[278]  Goldman Jm,et al.  New approaches in chronic granulocytic leukemia--origin, prognosis, and treatment. , 1982 .

[279]  Koeffler Hp,et al.  Chronic myelogenous leukemia--new concepts (first of two parts). , 1981 .

[280]  W. N. Burnette,et al.  "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. , 1981, Analytical biochemistry.

[281]  A. Sandberg.  Second International Workshop on Chromosomes in Leukemia. , 1980, Cancer research.

[282]  D. Baltimore,et al.  A transformation-defective mutant of Abelson murine leukemia virus lacks protein kinase activity. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[283]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[284]  D. Catovsky.  Ph1‐POSITIVE ACUTE LEUKAEMIA AND CHRONIC GRANULOCYTIC LEUKAEMIA: ONE OR TWO DISEASES? , 1979, British journal of haematology.

[285]  F. Reyes,et al.  The Blast Crisis of Chronic Granulocytic Leukaemia: Megakaryoblastic Nature of Cells as Revealed by the Presence of Platelet‐Peroxidase—A Cytochemical Ultrastructural Study , 1978, British journal of haematology.

[286]  G. Canellos,et al.  Erythroblastic transformation of chronic granulocytic leukemia. , 1977, The American journal of medicine.

[287]  G. Canellos,et al.  Basophilic Chronic Granulocytic Leukaemia with Hyperhistaminaemia , 1977, British journal of haematology.

[288]  B. Bain,et al.  Megakaryoblastic transformation of chronic granulocytic leukaemia. An electron microscopy and cytochemial study. , 1977, Journal of clinical pathology.

[289]  M. Greaves,et al.  Blast Crisis of Chronic Myeloid Leukaemia (CML): I. PRESENTATION SIMULATING ACUTE LYMPHOID LEUKAEMIA (ALL) , 1976, British journal of haematology.

[290]  G. Canellos,et al.  Chronic granulocytic leukemia. , 1976, The Medical clinics of North America.

[291]  E. Southern.  Detection of specific sequences among DNA fragments separated by gel electrophoresis. , 1975, Journal of molecular biology.

[292]  J. August,et al.  Structural Proteins of Mammalian Oncogenic RNA Viruses: Multiple Antigenic Determinants of the Major Internal Protein and Envelope Glycoprotein , 1974, Journal of virology.

[293]  J. Rowley.  A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining , 1973, Nature.

[294]  J. Gart,et al.  Cytogenetic studies in acute myelocytic leukemia with special emphasis on the occurrence of Ph1 chromosome. , 1970, Blood.

[295]  C. Bloomfield,et al.  Value of molecular monitoring during the treatment of chronic myeloid leukemia: a Cancer and Leukemia Group B study. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[296]  H. Kantarjian,et al.  Significance of cytogenetic clonal evolution in chronic myelogenous leukemia. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[297]  S. Bi,et al.  Retroviral transduction of Philadelphia-positive chronic myeloid leukemia cells with a human mutant p53 cDNA and its effect on in vitro proliferation. , 1994, Experimental hematology.

[298]  J. Melo,et al.  P190BCR-ABL chronic myeloid leukaemia: the missing link with chronic myelomonocytic leukaemia? , 1994, Leukemia.

[299]  H. Heimpel,et al.  New perspectives with interferon alpha. The German CML study group experience. , 1994, Bone marrow transplantation.

[300]  J. Melo,et al.  The ABL-BCR Fusion Gene Is Expressed in Chronic Myeloid Leukemia , 1993 .

[301]  M. Campbell,et al.  Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemia. , 1993, Hematologic pathology.

[302]  M. Rozman,et al.  Prognosis of chronic myeloid leukemia: studies from the Barcelona Group. , 1993, Leukemia & lymphoma.

[303]  F. Mitelman.  The cytogenetic scenario of chronic myeloid leukemia. , 1993, Leukemia & lymphoma.

[304]  H. Saito,et al.  Long persistent bcr-abl positive transcript detected by polymerase chain reaction after marrow transplant for chronic myelogenous leukemia without clinical relapse: a study of 64 patients. , 1993, Blood.

[305]  R. Berger.  Differences between blastic chronic myeloid leukemia and Ph-positive acute leukemia. , 1993, Leukemia & lymphoma.

[306]  M. Horowitz,et al.  Second HLA-identical sibling transplants for leukemia recurrence. , 1992, Bone marrow transplantation.

[307]  Sawyers Cl.  The bcr-abl gene in chronic myelogenous leukaemia. , 1992 .

[308]  R. Kurzrock,et al.  Minimal residual disease in interferon-treated chronic myelogenous leukemia: results and pitfalls of analysis based on polymerase chain reaction. , 1992, Leukemia.

[309]  D. Ginsburg,et al.  Prognostic significance of Philadelphia chromosome-positive cells detected by the polymerase chain reaction after allogeneic bone marrow transplant for chronic myelogenous leukemia. , 1992, Blood.

[310]  T. Yamada,et al.  The relationship between the site of breakpoints within the bcr gene and thrombopoiesis of Philadelphia-positive chronic myelocytic leukemia. , 1991, Leukemia research.

[311]  R. Kurzrock,et al.  Appearance of acute leukemia-associated P190BCR-ABL in chronic myelogenous leukemia may correlate with disease progression. , 1991, Leukemia.

[312]  I. Dubé,et al.  Chromosome Abnormalities in Chronic Myeloid Leukaemia , 1990 .

[313]  I. Dubé,et al.  Chromosome abnormalities in chronic myeloid leukaemia. A model for acquired chromosome changes in haematological malignancy. , 1990, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[314]  R. Gale,et al.  Ph-chromosome positive acute leukemias and acute phase CML: one or two diseases? Two. , 1990, Leukemia research.

[315]  P. Fenaux,et al.  Detection of minimal residual disease in chronic myeloid leukemia patients after bone marrow transplantation by polymerase chain reaction. , 1990, Leukemia.

[316]  C. Sawyers,et al.  Molecular relapse in chronic myelogenous leukemia patients after bone marrow transplantation detected by polymerase chain reaction. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[317]  J. Wiegant,et al.  Detection of the Philadelphia chromosome in interphase nuclei. , 1990, Cytogenetics and cell genetics.

[318]  M. Luppi,et al.  Chronic myelogenous leukemia with typical clinical and morphological features can be Philadelphia chromosome negative and "bcr negative". , 1990, Hematologic pathology.

[319]  B. Trask,et al.  Analytical approaches to detection and characterization of disease-linked chromosome aberrations. , 1990, Bone marrow transplantation.

[320]  R. Gale,et al.  Do chromosome abnormalities determine the type of acute leukemia that develops in CML? , 1990, Leukemia.

[321]  J. Trujillo,et al.  Chromosomal breakpoints within the first intron of the ABL gene are nonrandom in patients with chronic myelogenous leukemia. , 1990, Blood.

[322]  Larry J. Smith,et al.  Rearrangement and expression of p53 in the chronic phase and blast crisis of chronic myelogenous leukemia. , 1990, Blood.

[323]  C. Bartram,et al.  Detection of minimal residual leukemia by polymerase chain reactions. , 1990, Bone marrow transplantation.

[324]  R. Bernstein.  Cytogenetics of chronic myelogenous leukemia. , 1988, Seminars in hematology.

[325]  R. Storb,et al.  Second marrow transplants in patients with leukemia who relapse after allogeneic marrow transplantation. , 1988, Bone marrow transplantation.

[326]  C. Bartram.  Rearrangement of the c-abl and bcr genes in Ph-negative CML and Ph-positive acute leukemias. , 1988, Leukemia.

[327]  S. Smith,et al.  A new fused transcript in Philadelphia chromosome positive acute lymphocytic leukaemia , 1987, Nature.

[328]  Walker,et al.  Chromosomal abnormalities identify high-risk and low-risk patients with acute lymphoblastic leukemia. , 1986, Blood.

[329]  O. Witte,et al.  The complexity of virus--cell interactions in Abelson virus infection of lymphoid and other hematopoietic cells. , 1985, Advances in immunology.

[330]  M. Minamihisamatsu,et al.  Chromosome 9 in variant Ph translocations. , 1985, Cancer genetics and cytogenetics.

[331]  K B McCredie,et al.  Philadelphia chromosome-positive adult acute leukemia with monosomy of chromosome number seven: a subgroup with poor response to therapy. , 1983, Leukemia research.

[332]  E. Hook.  Exclusion of chromosomal mosaicism: tables of 90%, 95% and 99% confidence limits and comments on use. , 1977, American journal of human genetics.

[333]  P. Nowell,et al.  A minute chromosome in human chronic granulocytic leukemia , 1960 .